CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Current assets
Cash and cash equivalents	$ 38,225	$ 89,002
Accounts receivable, net	8,493	6,809
Inventory, net	16,200	17,307
Other current assets	7,065	9,225
Total current assets	69,983	122,343
Property and equipment, net	5,813	1,218
Capitalized software, net	4,974	4,973
Goodwill	5,516
Intangible assets, net	5,666
Operating lease right-of-use assets	3,376	1,877
Deferred tax asset	5,924	24,884
Total assets	101,252	155,295
Current liabilities
Accounts payable	4,374	4,155
Accrued expenses	8,185	8,497
Term loan, current	6,250	6,250
Deferred revenue, current	2,927	3,002
Earnout liabilities, current	100
Operating lease liabilities, current	482	311
Share repurchase liabilities, current	24,192
Total current liabilities	46,510	22,215
Term loan, net of current portion	102,548	106,630
Revolving loans	10,000
Deferred revenue, net of current portion	1,603	1,322
Operating lease liabilities, net of current portion	3,026	1,680
Share repurchase liabilities net of current portion	43,610
TRA liability	4,424	18,894
Earnout liabilities, net of current portion	16,355	41,100
Total liabilities	228,076	191,841
Commitments and contingencies (See Note 19)
Stockholders' Deficit
Preferred stock, $0.0001 par value, 10,000,000 shares authorized; no shares issued or outstanding as of September 30, 2024 and December 31, 2023
Additional paid-in capital	0	0
Accumulated deficit	(124,717)	(29,391)
Accumulated other comprehensive loss	(29)	(12)
Treasury stock, at cost	(5,600)
biote Corp.'s stockholders' deficit	(130,342)	(29,397)
Noncontrolling interest	3,518	(7,149)
Total stockholders' deficit	(126,824)	(36,546)
Total liabilities and stockholders' deficit	101,252	155,295
Class A Common Stock
Stockholders' Deficit
Common stock value	3	3
Class V Common Stock
Stockholders' Deficit
Common stock value	$ 1	$ 3